CFF-Championed Bill Eliminates Barriers to Participation in Clinical Trials for People with CF and other Rare Diseases
Site Search
EHE International Donates Premier Window Display for National CF Awareness Month in May
Expanded Research Lab to Apply Latest Scientific Advances -- Including Stem Cell Research and Gene Editing -- to Accelerate New Treatments for CF
More than 4,600 cystic fibrosis researchers and health care professionals gathered Oct. 27 - 29 in Orlando for the 30th annual North American Cystic Fibrosis Conference. Recordings of the three plenary sessions are now available online.
The Cystic Fibrosis Foundation announced the recipients of its fifth annual Impact Grants.
Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.
Engaged. Accountable. Curious. Authentic. These are the core values that drive the employees of the highly successful Atlanta-based insurance agency Snellings Walters every day. This year the company celebrates not only its 70th anniversary — but a decade of support for people with cystic fibrosis.
This executive summary highlights key content from articles reviewing the pathogenesis, diagnosis, and management of CF endocrine disorders.
The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of cystic fibrosis-related diabetes as well as to identify potential novel therapeutic strategies to manage and treat the disease.